Skip to content

Clinical trials

Phase 2 Muscular Atrophy, Spinal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Atrophy, Spinal Phase: Phase 2 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20072
20081
20111
20131
20153
20164
20172
20194
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Biogen3
Scholar Rock, Inc.2
University of Utah2
Catalyst Pharmaceuticals, Inc.1
Charite University, Berlin, Germany1
Cytokinetics1
Duke University1
Flex Pharma, Inc.1
Hugh McMillan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Atrophy, Spinal25
Amyotrophic Lateral Sclerosis4
Spinal Muscular Atrophies of Childhood4
Motor Neuron Disease3
Muscle Cramp2
Neuromuscular Diseases2
Neuromuscular Manifestations2
Arthrogryposis1
Atrophy1
Bulbo-Spinal Atrophy, X-Linked1

Trials

Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.